Gossamer Bio to Announce Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call and Webcast on March 3, 2022

Rhea-AI Summary

Gossamer Bio, Inc. (GOSS) will announce its fourth quarter and full-year 2021 financial results on March 3, 2022. A live conference call and webcast will follow at 4:30 p.m. ET that same day, where management will discuss the financial results and provide a corporate update. Investors can access the live webcast at this link, with a replay available for 30 days on the company’s website. Gossamer Bio focuses on developing therapeutics for immunology, inflammation, and oncology.

SAN DIEGO--(BUSINESS WIRE)-- Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that it will report its fourth quarter and full-year 2021 financial results on Thursday, March 3, 2022.

In connection with the earnings release, Gossamer’s management team will host a live conference call and webcast at 4:30 p.m. ET on Thursday, March 3, 2022, to discuss the Company’s financial results and provide a corporate update.

Conference ID: 2791984
Domestic Dial-in Number: (833) 646-0603
International Dial-in Number: (929) 517-9782
Live Webcast: https://edge.media-server.com/mmc/p/ci4evdm2

A replay of the audio webcast will be available for 30 days on the Investors section of the Company's website, www.gossamerbio.com.

About Gossamer Bio

Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220228005298/en/

For Investors and Media:

Bryan Giraudo, Chief Financial Officer & Chief Operating Officer

Gossamer Bio Investor Relations

ir@gossamerbio.com

Source: Gossamer Bio, Inc.

FAQ

When will Gossamer Bio report its fourth quarter financial results?

Gossamer Bio will report its fourth quarter financial results on March 3, 2022.

What time is the Gossamer Bio earnings conference call?

The earnings conference call will be held at 4:30 p.m. ET on March 3, 2022.

How can I access the Gossamer Bio earnings webcast?

You can access the Gossamer Bio earnings webcast at this link: https://edge.media-server.com/mmc/p/ci4evdm2.

What is the focus of Gossamer Bio's business?

Gossamer Bio focuses on discovering and developing therapeutics in immunology, inflammation, and oncology.